Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents
- PMID: 15243085
- PMCID: PMC446272
- DOI: 10.1128/JCM.42.7.3219-3224.2004
Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents
Abstract
Detection of Chlamydia pneumoniae antigens in PCR-negative atheromata by immunohistochemistry assays has given rise to controversies regarding a link between the bacterium and atherosclerosis. One hundred ninety-seven human arterial segments removed surgically were examined for C. pneumoniae DNA by conventional PCR with three different primer pairs and by real-time PCR in two different laboratories. No C. pneumoniae DNA was detected. Eighty atherosclerotic lesions were studied by immunohistochemistry assays. Immunoreactivity for C. pneumoniae was frequently present but was not related to the extent of atherosclerosis. Mammary arteries showed immunoreactivity. Serial sections of 17 atheromata were analyzed by Western blotting, histological staining, and UV fluorescence microscopy. Chlamydial proteins were not detected. The sites with positive results by C. pneumoniae immunohistostaining assays precisely matched the sites with autofluorescent ceroid deposits. Immunoblotting and antigenic staining for C. pneumoniae were negative in tests with fetal aortas. The absence of C. pneumoniae DNA in human atherosclerotic lesions, together with negative results for C. pneumoniae proteins by Western blotting analysis, and the perfect matching of C. pneumoniae immunoreactive sites with sites with autofluorescent ceroid deposits suggest a nonspecific reactivity of antichlamydial antibodies with plaque constituents. On the basis of the results of the present study, there are no arguments for an etiologic role of C. pneumoniae in atherosclerosis.
Figures

Similar articles
-
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old).Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6911-4. doi: 10.1073/pnas.92.15.6911. Proc Natl Acad Sci U S A. 1995. PMID: 7624342 Free PMC article.
-
Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures.J Clin Microbiol. 2003 Apr;41(4):1454-7. doi: 10.1128/JCM.41.4.1454-1457.2003. J Clin Microbiol. 2003. PMID: 12682129 Free PMC article.
-
Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease.Atherosclerosis. 1998 Oct;140 Suppl 1:S25-30. doi: 10.1016/s0021-9150(98)00117-8. Atherosclerosis. 1998. PMID: 9859922 Clinical Trial.
-
Chlamydia pneumoniae in atherosclerotic tissue.J Infect Dis. 2000 Jun;181 Suppl 3:S437-40. doi: 10.1086/315614. J Infect Dis. 2000. PMID: 10839732 Review.
-
Chlamydia pneumoniae and atherosclerosis.Verh K Acad Geneeskd Belg. 2001;63(5):433-45; discussion 446. Verh K Acad Geneeskd Belg. 2001. PMID: 11813502 Review.
Cited by
-
Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.J Clin Microbiol. 2005 Mar;43(3):1325-9. doi: 10.1128/JCM.43.3.1325-1329.2005. J Clin Microbiol. 2005. PMID: 15750103 Free PMC article. Clinical Trial.
-
Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens.J Clin Microbiol. 2007 Feb;45(2):421-5. doi: 10.1128/JCM.00894-06. Epub 2006 Dec 13. J Clin Microbiol. 2007. PMID: 17166966 Free PMC article.
-
Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques.Mediators Inflamm. 2011;2011:941396. doi: 10.1155/2011/941396. Epub 2011 Oct 2. Mediators Inflamm. 2011. PMID: 21976788 Free PMC article. Review.
-
Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004).J Clin Microbiol. 2006 Mar;44(3):899-908. doi: 10.1128/JCM.44.3.899-908.2006. J Clin Microbiol. 2006. PMID: 16517874 Free PMC article.
-
Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.J Clin Microbiol. 2005 Jan;43(1):19-24. doi: 10.1128/JCM.43.1.19-24.2005. J Clin Microbiol. 2005. PMID: 15634945 Free PMC article. Review. No abstract available.
References
-
- Apfalter, P., F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, M. Maass, A. Makristathis, A. Meijer, R. Nadrchal, K. Persson, M. L. Rotter, C. Y. W. Tong, G. Stanek, and A. M. Hirschl. 2001. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J. Clin. Microbiol. 39:519-524. - PMC - PubMed
-
- Apfalter, P., O. Assadian, F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, A. Makristathis, M. Nehr, M. L. Rotter, and A. M. Hirschl. 2002. Reliability of nested PCR for detection of Chlamydia pneumoniae in atheromas: results from a multicenter study applying standardized protocols. J. Clin. Microbiol. 40:4428-4434. - PMC - PubMed
-
- Ball, R. Y., K. L. H. Carpenter, and M. J. Mitchinson. 1987. What is the significance of ceroid in human atherosclerosis? Arch. Pathol. Lab. Med. 111:1134-1140. - PubMed
-
- Berg, H. F., B. Maraha, A. M. C. Bergmans, A. Van der Zee, J. A. J. W. Kluytmans, and M. F. Peeters. 2003. Extraction of Chlamydia pneumoniae DNA from vascular tissue for use in PCR: an evaluation of four procedures. Clin. Microbiol. Infect. 9:135-139. - PubMed
-
- Binder, C. J., S. Hörkkö, A. Dewan, M. K. Chang, E. P. Kieu, C. S. Goodyear, P. X. Shaw, W. Palinski, J. L. Witztum, and G. J. Silverman. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9:736-743. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources